CD44 and prostate carcinoma: Furthermore, NF-κB and ALDH activities as well as CD44+ cells have all been highlighted as markers of prostate cancer cell migration (Klarmann et al, 2009; Zhang et al, 2009b; van den Hoogen et al, 2010).